Federal Register notice: FDA announces an opportunity for public comment on an information collection extension for the agency guidance entitled Forma...
Federal Register notice: FDA has made available a draft guidance entitled Epidermolysis Bullosa (EB): Developing Drugs for Treatment of Cutaneous Mani...
University of Ottawa law professor Amir Attaran suggests that the Canadian government should look at suspending U.S. drug patents as the Trump Adminis...
Federal Register notice: FDA establishes a public docket to receive information, recommendations, and comments on matters related to its publication o...
FDA lifts a clinical hold against Solid Biosciences Phase 1/2 clinical trial for its investigational microdystrophin gene transfer, SGT-001, for treat...
FDA clears an Arcuro Medical 510(k) for its SuperBall meniscus repair system.
FDA Review posts the Federal Register notices for the week ending 6/15/2018.
FDA makes available a guidance entitled Epidermolysis Bullosa (EB): Developing Drugs for Treatment of Cutaneous Manifestations.